| Year |
Citation |
Score |
| 2014 |
Carr R, Du Y, Quoyer J, Panettieri RA, Janz JM, Bouvier M, Kobilka BK, Benovic JL. Development and characterization of pepducins as Gs-biased allosteric agonists. The Journal of Biological Chemistry. 289: 35668-84. PMID 25395624 DOI: 10.1074/Jbc.M114.618819 |
0.675 |
|
| 2014 |
Armando S, Quoyer J, Lukashova V, Maiga A, Percherancier Y, Heveker N, Pin JP, Prézeau L, Bouvier M. The chemokine CXC4 and CC2 receptors form homo- and heterooligomers that can engage their signaling G-protein effectors and βarrestin. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 4509-23. PMID 25053617 DOI: 10.1096/Fj.13-242446 |
0.365 |
|
| 2013 |
Quoyer J, Janz JM, Luo J, Ren Y, Armando S, Lukashova V, Benovic JL, Carlson KE, Hunt SW, Bouvier M. Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein. Proceedings of the National Academy of Sciences of the United States of America. 110: E5088-97. PMID 24309376 DOI: 10.1073/Pnas.1312515110 |
0.632 |
|
| 2011 |
Dalle S, Quoyer J, Varin E, Costes S. Roles and regulation of the transcription factor CREB in pancreatic β -cells. Current Molecular Pharmacology. 4: 187-95. PMID 21488836 DOI: 10.2174/1874467211104030187 |
0.412 |
|
| 2009 |
Broca C, Quoyer J, Costes S, Linck N, Varrault A, Deffayet PM, Bockaert J, Dalle S, Bertrand G. beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells. The Journal of Biological Chemistry. 284: 4332-42. PMID 19074139 DOI: 10.1074/Jbc.M807595200 |
0.336 |
|
| 2007 |
Binet V, Duthey B, Lecaillon J, Vol C, Quoyer J, Labesse G, Pin JP, Prézeau L. Common structural requirements for heptahelical domain function in class A and class C G protein-coupled receptors. The Journal of Biological Chemistry. 282: 12154-63. PMID 17310064 DOI: 10.1074/Jbc.M611071200 |
0.593 |
|
| Show low-probability matches. |